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ABSTRACT
Autoimmune regulator (AIRE) is a transcription
factor that induces the expression of a large subset
of otherwise strictly tissue restricted antigens in
medullary thymic epithelial cells, thereby enabling
their presentation to developing T cells for negative
selection. Mutations in AIRE lead to autoimmune-
polyendocrinopathy-candidiasis-ectodermal dystro-
phy (APECED), a rare monogenetic disease.
Although it has been reported that AIRE interacts
with proteins involved in nuclear transport, DNA-
damage response, chromatin remodeling, transcrip-
tion and pre-mRNA-splicing, the precise mechanism
of AIRE-induced tissue restricted antigen expres-
sion has remained elusive. In this study, we in-
vestigated an APECED patient mutation that
causes the loss of the extreme C-terminus of AIRE
and found that this mutant protein is transcript-
ionaly inactive. When tethered heterologously to
DNA, this domain could stimulate transcription
and splicing by itself. Moreover, the loss of this
C-terminus disrupted interactions with the positive
transcription elongation factor b (P-TEFb). Via P-TEFb,
AIRE increased levels of RNA polymerase II on and
enhanced pre-mRNA splicing of heterologous and
endogenous target genes. Indeed, the inhibition of
CDK9, the kinase subunit of P-TEFb, inhibited AIRE-
induced pre-mRNA splicing of these genes. Thus,
AIRE requires P-TEFb to activate transcription
elongation and co-transcriptional processing of
target genes.
INTRODUCTION
Tolerance to self is an essential element of the immune
system and when tolerance is dysfunctional, autoimmune
diseases can arise. Central tolerance is established by
negative selection of developing T cells in the thymus
(1). Most autoimmune diseases are dependent on many
genetic loci, but a rare autoimmune disease,
autoimmune-polyendocrinopathy-candidiasis-ectodermal
dystrophy (APECED) is monogenetic. APECED patients
have mutations in the AIRE gene (2,3), which encodes the
autoimmune regulator (AIRE). AIRE is critical for the
expression of a number of otherwise tissue restricted
antigens (TRAs) in medullary thymic epithelial cells
(mTECs) (4). Indeed, Aire
 /  mice develop multi-organ
autoimmunity with inﬂammatory inﬁltrates and auto-
reactive antibodies, which is caused by dysregulated nega-
tive selection of developing T cells in the thymus (4),
whereas the severity and organs affected are strain de-
pendent (5–7). mTECs from these mice express a much
smaller TRA repertoire than their wild-type (WT)
counterparts.
Previous studies suggested a role for AIRE in tran-
scription (8). AIRE is localized to the nucleus where it
accumulates in distinct nuclear structures (9), and when
expressed transiently, it activates the expression of en-
dogenous genes as well as exogenous plasmid targets
(10). In addition, AIRE interacts with the CREB-
binding protein (11) and the positive transcription elong-
ation factor b (P-TEFb) (10). AIRE contains several
domains that are present in various transcription factors.
First, it has a Sp100, Aire-1, NucP41/75 and DEAF-1
domain (SAND) that has been suggested to bind DNA
(12). Second, AIRE contains two plant homeodomains
(PHD1 and PHD2). PHD1 binds to histone-3 with
non-methylated lysine at position 4 (H3K4me
0) (13,14),
which is abundant in transcriptionaly inactive chromatin.
It was also proposed to be an E3-ubiquitin ligase (15).
PHD2 might represent an accessory transcription activa-
tion domain (TAD) (16,17). Furthermore, AIRE can also
associate with proteins involved with nuclear transport,
DNA-damage response, chromatin remodeling, transcrip-
tion and pre-mRNA splicing (18).
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ase II (RNAPII) and their expression is regulated at many
different steps (19). The C-terminal domain (CTD) of
human Rbp1, the largest RNAPII subunit, consists of
52 Y1S2P3T4S5P6S7 heptapeptide repeats. Serine residues
in these repeats are phosphorylated by different CTD-
kinases. Thus, the pattern of CTD phosphorylation
changes dynamically as the RNAPII transitions through
different phases of transcription (20). CTD phosphory-
lated at serine-5 (S5P) is a hallmark of transcription initi-
ation, and is accomplished by cyclin-dependent kinase 7
(CDK7), a component of the general transcription factor
TFIIH (21). On the other hand, CTD phosphorylated at
serine-2 (S2P) is a hallmark of transcription elongation,
and is catalyzed by P-TEFb (22), composed of the CDK9
kinase and the regulatory cyclins T1 or T2a/b (23).
Furthermore, pre-mRNA splicing occurs co-transcrip-
tionaly, and the phosphorylated CTD is bridging these
processes by binding components of pre-mRNA splicing
and cleavage/polyadenylation machineries (24,25). Thus,
pre-mRNA processing factors associate with the tran-
scription elongation complex and the degree and type of
CTD phosphorylation deﬁne the speciﬁcity and afﬁnity of
these interactions (26).
In this study, we examined the functional relevance of
AIRE’s C-terminus by characterizing the molecular defect
of an APECED patient mutation in AIRE. A previous
report demonstrated that AIRE binds P-TEFb (10). We
now mapped this interaction to the C-terminal 40 residues
of AIRE and validated this ﬁnding with biochemical and
functional assays. Indeed, our ﬁndings reveal that the
C-terminal 40 residues of AIRE are critical for the recruit-
ment of P-TEFb to target genes, leading to increased
phosphorylation of the CTD, transcription elongation
and pre-mRNA splicing.
MATERIALS AND METHODS
Cell lines
HeLa and 293T cells were obtained from ATCC and
cultured in DMEM supplemented with 10% FBS and
antibiotics. Mouse 1C6 mTECs were a kind gift from
Dr M. Kasai [National Institute of Infectious Diseases,
Tokyo, Japan (27)] and were cultured in S-MEM
(Invitrogen) supplemented with 10% FBS (Invitrogen),
5mM Glutamax (Invitrogen), 0.2mM b-mercaptoethanol
(Invitrogen), 0.5mg/ml hydrocortisone hemisuccinate
(Sigma-Aldrich) and 1mM sodium pyruvate (Invitrogen).
Plasmids
Flag-AIRE was a kind gift from Dr M. Matsumoto
[University of Tokushima, Kuramoto, Tokushima,
Japan (15)] and GAL.AIRE was a kind gift from
Dr P. Peterson (University of Tartu, Tartu, Estonia).
hINSLuc was kind gift from Dr M. German (UCSF,
San Francisco, CA, USA). G5HIV2SVEDA was a kind
gift from Dr R. Kornbliht [Universidad de Buenos Aires,
Buenos Aires, Argentina (28)] and G5HIV2dsx±ESE
were a kind gift from Dr J. Blencowe [University of
Toronto, Toronto, Ontario, Canada (29)]. G5CAT has
been previously described (30). HA-CDK9 and myc-
cyclinT1 have been previously described (31,32).
The 505fsx520 mutation was generated in WT
GAL.AIRE and WT Flag-AIRE by PCR mutagenesis
using primers: (forward) AGGATGACACTCCAGTCA
CGAGC and (reverse) GCTCGTGACTGGAGTGTCA
TCCT. GAL.AIRE deletion mutants were generated
with PCR mutagenesis deletion with QuikChange II XL
Site-Directed Mutagenesis Kit (Stratagene) using primers:
425F TTGACTGTATCGCCGGAATTCCAGCAGAA
CCTGGCTCCTGGT and
425R ACCAGGAGCCAGGTTCTGCTGGAATTCCG
GCGATACAGTCAA;
488F ACTGTATCGCCGGAATTCCTGGCCCCCAGC
CCCGCC and
488R GGCGGGGCTGGGGGCCAGGAATTCCGGC
GATACAGT.
Luciferase assay
1C6 mTECs were plated onto 6-well plates and transfected
using Fugene 6 (Roche) to co-express empty plasmid
vector, Flag-AIRE or Flag-AIREfsx, and hINSLuc and
pRL-CMV (Promega). Cells were harvested after 24h
and luciferase assays were performed using the Dual
Luciferase kit (Promega) according to the manufacturer’s
instructions. Fireﬂy luciferase activity of each sample was
normalized to renilla luciferase readings. Averages were
calculated from at least three separate transfections.
Fold activation represents the ratio between the effector
activated transcription and the activity of the reporter
with empty vector. Error bars represent SEM.
CAT assay
1C6 cells were transfected with Fugene 6 (Roche) to
co-express G5CAT and GAL-chimeras. CAT assays
were performed as in Oven et al. (10) and are described
in detail in Supplementary Methods.
RNA isolation and RT–PCR
Cells were harvested in Trizol (Invitrogen) and RNA was
isolated according to manufacturer’s speciﬁcations. RNA
was treated with DNAfree (Ambion) and reverse
transcribed with M-MLV RT (Invitrogen) with random
or speciﬁc primers. Detailed protocol and primers are
described in Supplementary Methods.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) protocol was
adapted from Carey et al. (33), and is described in detail
in Supplementary Methods.
Co-immunoprecipitation
293T cells were transfected with plasmids encoding HA-
CDK9, Myc-Cyc T1 and GAL, WT GAL.AIRE or
mutant GAL.AIREfsx fusion proteins using calcium
phosphate. Cells were harvested and resuspended in hypo-
tonic buffer (10mM HEPES pH 7.5, 1.5mM MgCl2,
10mM KCl, 5mM EDTA, 0.05% NP-40, 1mM DTT)
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Aldrich) and incubated on ice for 15min. Cell lysates
were centrifuged for 10min at 1000g (4 C) and super-
natant was removed as completely as possible and dis-
carded. Nuclei were resuspended in sonication buffer
(20mM HEPES pH 7.5, 150mM NaCl, 1.5mM MgCl2,
0.2mM EDTA, 0.1% NP-40, 1mM DTT) supplemented
with protease inhibitor cocktail and gently sonicated on a
Bandelin sonoplus soniﬁer (2 10s pulse at power setting
20%, on ice at all times). Nuclear lysates were centrifuged
at maximum speed for 20min to remove insoluble material
and supernatants were used for immunoprecipitation.
Two micrograms of antibodies were added and the samples
were incubated 4h at 4 C, then protein G Dynabeads
(Invitrogen) were added and samples were incubated
1 additional hour. Precipitates were washed at room
temperature four times with cold PBS supplemented
with 0.05% NP-40 and protease inhibitor cocktail.
Precipitated proteins were eluted by addition of 1 
SDS–PAGE loading buffer and heating to 95 C for
5min. Precipitates were separated by SDS–PAGE and
proteins were detected with speciﬁc antibodies by
western blotting.
Antibodies and chemicals
Antibodies used for western blotting, co-immunoprecipi-
tation (co-IP), ChIP or immunoﬂuorescence: anti-AIRE
(sc-33188 Santa Cruz Biotechnology), anti-Flag (M2
Sigma-Aldrich), anti-CDK9 (sc-484 Santa Cruz
Biotechnology, ab10874 Abcam), anti-RNAPII (ab5408
Abcam, MMS-126R Covance), anti-S2P (ab5095
Abcam), anti-GAL (sc-510 Santa Cruz Biotechnology),
anti-GAPDH (AM4300 Ambion), anti-a Tubulin
(DM1A Sigma-Aldrich), anti-U5-116 kD (A300-957A
Bethyl labs) rabbit and mouse control IgG (Santa Cruz
Biotechnology). Flavopiridol was obtained from
Sigma-Aldrich.
RESULTS
The frame-shift mutant AIRE protein cannot activate
transcription
To reveal how AIRE induces the expression of TRAs, we
focused on an APECED patient mutation in AIRE,
which encodes the frame-shift mutant AIRE 505fsx520
(AIREfsx) protein with a truncated C-terminus, whose
other domains important for homodimerization and re-
cruitment to chromatin remain intact. The mutation was
identiﬁed in two siblings with APECED by Ishii et al. (34).
It represents a deletion of a guanosine at position 1640,
which introduces a reading frame-shift at residue 505 and
causes premature termination at residue 520 in the mutant
AIREfsx protein. A schematic representation of AIRE
protein domains and changes caused by the reading
frame-shift mutation are depicted in Figure 1A and B. To
characterize functionally the mutant AIREfsx protein, we
used a co-transfection assay with plasmid effectors and a
luciferase reporter target that was under the control of
the human insulin promoter (hINSLuc) (Figure 1C).
When the WT AIRE protein was co-expressed transiently,
the luciferase activity of hINSLuc was 35-fold over that
of the empty plasmid vector (Figure 1C, compare lanes 2
and 1), whereas the mutant AIREfsx protein was inactive
(Figure 1C, compare lanes 3 and 1).
We also examined the expression of Ins2, an endogen-
ous TRA gene (Figure 1D). Levels of mouse Ins2 tran-
scripts from 1C6 mTECs transiently expressing WT AIRE
or mutant AIREfsx proteins were quantiﬁed. While the
WT AIRE protein induced Ins2 mRNA expression
6-fold (Figure 1D, compare lanes 2 and 1), the mutant
AIREfsx protein had no effect (Figure 1D, compare lanes
3 and 1). Similar levels of WT AIRE and mutant AIRE
proteins were expressed in these cells (Figure 1C, D).
AIRE is localized to the nucleus and has a typical
punctate staining in AIRE-expressing mTECs in the thy-
mus (35,36) as well as in transfected cells of various types
(9). We also localized WT AIRE and mutant AIREfsx
proteins in HeLa cells (Supplementary Figure S1). All
examined AIRE proteins were found in the nucleus.
However, while the WT AIRE protein showed a discrete
punctuate staining, the mutant AIREfsx protein staining
revealed a more dispersed pattern. Similar dispersed nu-
clear staining was also observed for a C-terminally deleted
mutant AIRE (1–509) protein, conﬁrming that it was
indeed due to the loss of a functional C-terminus rather
than mediated by the new C-terminal residues encoded by
the frame-shifted reading frame. We conclude that the
C-terminus of AIRE is required for the expression of
TRAs and for the punctate nuclear distribution character-
istic of the WT AIRE protein.
The C-terminus of AIRE is an autonomous TAD
To examine if the C-terminus of AIRE can act as an in-
dependent TAD, we fused WT and different N-terminally
truncated versions of AIRE as well as those bearing the
505fsx520 mutation to the GAL4 DNA-binding domain
(GAL) (Figure 2, left panel). These fusion proteins were
expressed transiently in 1C6 mTECs with G5CAT, con-
sisting of a CAT reporter gene with ﬁve GAL4 upstream
activating sequences (UASs) in its promoter. WT
GAL.AIRE fusion protein activated G5CAT  20-fold
over GAL (Figure 2, middle panel, compare lanes 1
and 2). A similar activation was observed for the GAL.
AIRE425 fusion protein (Figure 2, middle panel, lane 3),
which included only the PHD2 and the C-terminus of
AIRE. Importantly, the GAL.AIRE488 chimera,
including only the C-terminus, also activated G5CAT
12-fold (Figure 2, middle panel, lane 4). In contrast,
none of the mutant AIREfsx proteins (Figure 2, middle
panel, lanes 5–7) activated this plasmid target. The expres-
sion and size of mutant fusion proteins was conﬁrmed in
cells (Figure 2, right panel). Of note, transcriptionaly
inactive mutant proteins were more stable than their WT
counterparts (Figure 2, right panel, compare lanes 2–4 and
5–7). Tethering AIRE to GAL enabled us to examine
transcription activation independent of recruitment,
thereby speciﬁcally mapping the core TAD to the 57
residues in the C-terminus of AIRE. The increased stabil-
ity of our mutant proteins agrees with a previous
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Figure 1. The mutant AIREfsx protein does not activate transcription. (A) Schematic representation of WT AIRE and mutant AIREfsx proteins.
From the N-terminus, domains are: homogenously staining region (HSR); nuclear localization signal (NLS), Sp100, Aire-1, NucP41/75 and DEAF-1
domain (SAND); plant homeodomains 1 and 2 (PHD); proline rich region (PRR); WT (C) and mutant alternative (fsx) C-termini. On top, numbers
refer to borders of PHD2 and the full length Aire protein. Below numbers refer to the ﬁrst frame-shifted residue and the end of the termination
sequence (505fsx520). (B) Residues in the C-terminus of WT and mutant AIREfsx proteins. Numbers are as in (A). Changed residues are presented
with italic letters. (C) Mutant AIREfsx protein does not activate transcription. Relative luciferase activity of plasmid target (hINSLuc) for WT AIRE
and mutant AIREfsx proteins is presented as fold activation above the empty plasmid vector (C). Values represent the average of three independent
transfections with standard errors of the mean (SEM) represented by error bars. Expression levels for AIRE proteins are presented below the bar
graph (WB). (D) Mutant AIREfsx protein does not induce expression of the mouse Ins2 gene. mIns2 RNA levels from WT AIRE and mutant
AIREfsx protein expressing 1C6 mTECs are presented as fold activation above the empty plasmid vector (C). Values represent the average of three
independent transfections with SEM represented by error bars. Levels of Ins2 RNA were normalized to b-actin. Expression levels for AIRE proteins
are presented below the bar graph (WB).
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Figure 2. The C-terminus of AIRE is an autonomous TAD. In the left panel is a schematic representation of GAL fusion proteins and their names.
The CAT activity of the plasmid target (G5CAT) for the WT and mutant GAL.AIRE fusion proteins in 1C6 mTECs is presented as fold activation
above that for GAL alone. Values represent the average of three independent transfections with SEM represented by error bars. Panel on the right
presents expression levels of GAL and GAL.AIRE chimeras (WB).
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half-lives in cells (37). We conclude that the 57 residues of
AIRE C-terminus represent a necessary and sufﬁcient
TAD of AIRE.
The C-terminus of AIRE interacts with P-TEFb
Given the functional importance of the C-terminus of
AIRE, we wanted to determine if it mediates its inter-
actions with P-TEFb (10). Therefore, we performed co-
immunoprecipitations (co-IPs) from HeLa cells transiently
expressing epitope-tagged CDK9 protein together with
GAL, WT GAL.AIRE or mutant GAL.AIREfsx fusion
proteins (Figure 3A). AIRE does not require a cell-speciﬁc
co-factor (13,18). Since other cell lines beside mTECs were
used in most publications, we used HeLa cells for our
binding studies. As expected, CDK9 was co-precipitated
with the WT GAL.AIRE fusion protein (Figure 3A,
lane 2) but not with GAL (Figure 3A, lane 1). In
contrast, no such interaction was observed with the
mutant GAL.AIREfsx fusion protein (Figure 3A, lane 3).
To determine if the loss of P-TEFb binding abolished
target gene recruitment of P-TEFb by the mutant
AIREfsx protein, we performed ChIPs with anti-CDK9
antibodies. Recruitment of AIRE to its target genes
depends on the binding between PHD1 and H3K4me
0
(13,14) and as yet undetermined other interactions.
Thus, to isolate our study from issues related to AIRE
recruitment to DNA, we also chose the GAL-tethering
approach for these experiments. We used
G5HIV2SVEDA, containing from the 50 direction 5
UASs, the TATA box from the HIV2 promoter, and a
1.5kb fragment with the human a-globin gene, into
whose third exon a 3kb fragment from the human ﬁbro-
nectin 1 gene was inserted (Figure 3B) (28). This plasmid
target has a long coding region (4kb), which was optimal
for our ChIP-qPCR analyses (promoter (Pr), 50- and
30-ends of the gene and polyadenylation site (pA), and a
control untranscribed region (U)). Furthermore, this plas-
mid target had low basal levels of expression but could be
induced potently by the co-expression with a GAL-fused
TAD (28) such as the WT GAL.AIRE fusion protein
(Supplementary Figure S2). The target gene analyzed in
our ChIPs is depicted on top of Figure 3B. Below it are
presented our amplicons for ChIP. Due to its artiﬁcial
nature, primers designed to amplify different regions of
G5HIV2SVEDA were speciﬁc for the plasmid target and
did not amplify endogenous cellular genes. Indeed, we
observed 1.5- to 2.5-fold enrichment of P-TEFb on this
gene (Figure 3B, lower panel, black bars, Pr, 50,3 0 and pA
amplicons) above background levels (Figure 3B, lower
panel, black bar, U amplicon) in cells expressing the WT
GAL.AIRE fusion protein. In contrast, even though tran-
siently expressed proteins were expressed at comparable
levels (Supplementary Figure S3) the mutant GAL.
AIREfsx fusion protein failed to recruit P-TEFb to
G5HIV2SVEDA (Figure 3B, compare striped and black
bars), thus establishing the functional role for interactions
between P-TEFb and the C-terminus of AIRE in this pro-
cess. Based on these results, we conclude that the AIRE
TAD recruits P-TEFb to target genes and that the mutant
AIREfsx protein has lost this property.
AIRE increases the phosphorylation of the CTD
Since our assays deﬁned the AIRE TAD and its inter-
actions with P-TEFb, we wanted to analyze the phosphor-
ylation of CTD on AIRE-induced genes. Since CDK9
phosphorylates S2P, we focused on this modiﬁcation.
G5HIV2SVEDA was co-expressed transiently with the
WT GAL.AIRE or mutant GAL.AIREfsx fusion proteins
in HeLa cells. Targeting of GAL fusion proteins to
G5HIV2SVEDA was veriﬁed by ChIP with anti-GAL
antibodies (Figure 4B). Indeed, the WT GAL.AIRE and
mutant GAL.AIREfsx fusion proteins were recruited to
DNA at comparable levels (Figure 4B, black and striped
bars). Moreover, we observed a high occupancy of
our GAL fusion proteins at the promoter (Pr) where the
UASs are located (Figure 4B, black and striped bars, Pr).
The 50 amplicon was also enriched in the GAL ChIP,
although these levels were approximately 20-fold lower
than those for the Pr amplicon (Figure 4B, black
and striped bars, compare Pr and 50 amplicon). We
conclude that our assay had a high resolution and the
fusion proteins were recruited to DNA at comparable
levels.
Whereas we found  2-fold more RNAPII on the gene
and at polyadenylation signal (Figure 4C, compare black
and striped bars, 50,3 0 and pA amplicons) in WT
GAL.AIRE fusion protein-expressing cells compared to
levels in mutant GAL.AIREfsx fusion protein-expressing
cells or to levels in the untranscribed region (Figure 4C,
compare black, U amplicon), its levels in the promoter
A
CDK9
αGAL IP
WB:
5%
input
CDK9
GAL
B
IP:WB
GAL
GAL.AIRE
GAL.AIREfsx
+
+
+
1      2     3
GAL.AIRE
G5HIV2SVEDA T
AATAAA UAS
αgl FN1
U A p ’ 3 ’ 5 r P
GAL.AIREfsx
Figure 3. Mutant AIREfsx protein does not interact with P-TEFb.
(A) Mutant AIREfsx protein does not interact with CDK9. GAL,
GAL.AIRE and GAL.AIREfsx chimeras were expressed in HeLa
cells. Proteins were immunoprecipitated with anti-GAL antibodies
(aGAL) and the co-immunoprecipitation with CDK9 was detected
with anti-CDK9 antibodies by western blotting (Top panel, IP:WB).
The lower three panels contain 5% of input proteins for immunopre-
cipitations (WB). (B) Mutant AIREfsx protein cannot recruit CDK9 to
DNA. Sonicated lysates from HeLa cells co-expressing GAL.AIRE or
GAL.AIREfsx fusion proteins and G5HIV2SVEDA were immunopre-
cipitated with anti-CDK9 (aCDK9) antibodies for ChIP. Enrichment
of amplicons is presented as fold enrichment over IgG control (CDK9/
IgG). Black and striped bars represent values for the WT GAL.AIRE
and mutant GAL.AIREfsx chimeras with SEM depicted by error bars.
G5HIV2SVEDA and ChIP amplicons are depicted above and below
the bar graph, respectively (promoter, Pr; 50-end of gene, 50;3 0-end of
gene, 30, polyadenylation signal, pA; untranscribed region, U).
G5HIV2SVEDA contains ﬁve GAL binding sites (UAS) and the
TATA box (T) upstream of the a-globin gene (agl) with the inserted
fragment from the ﬁbronectin 1 gene (FN1).
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GAL.AIRE and mutant GAL.AIREfsx chimeras
(Figure 4C, compare black and striped bars, Pr). Since
the occupancy of RNAPII at the promoter in cells express-
ing the mutant GAL.AIREfsx fusion protein was above
that at the untrancribed amplicon (U), this ﬁnding indi-
cates that RNAPII is recruited to the promoter independ-
ently of its interaction with P-TEFb.
In contrast, levels of S2P were markedly higher on the
gene in the presence of the WT GAL.AIRE fusion protein
compared to the mutant GAL.AIREfsx fusion protein
(Figure 4D, compare black and striped bars, 30 and pA
amplicons). Indeed, levels were  2-fold above those from
mutant GAL.AIREfsx fusion protein-expressing cells in
the promotor (Pr) and 50-end of the gene, 3-fold in the
30-end of the gene and 8-fold at the polyadenylation site
(pA) (Figure 4D, compare black and striped bars). To
determine relative levels of S2P, we divided amounts of
S2P by those of RNAPII for each amplicon. When they
were examined in WT GAL.AIRE fusion protein-
expressing cells and compared to the untranscribed region
(U), 1.5-, 2- and 3-fold enrichment was observed at the
promoter (Pr), at the 30-end of the gene (30) and at the
polyadenylation site (pA), respectively (Figure 4E, black
bars). In contrast, in mutant GAL.AIREfsx fusion
protein-expressing cells, relative S2P levels throughout
the gene were equivalent to those of the untranscribed
region (U) (Figure 4E, striped bars). Thus, AIRE-
induced activation of transcription is associated with
elevated levels of RNAPII and S2P in the body and
30-end of the gene, which depend on the AIRE TAD.
AIRE increases pre-mRNA splicing
Since pre-mRNA splicing is a co-transcriptional process
inﬂuenced by CTD phosphorylation, we wanted to
examine its regulation by AIRE. We used G5HIV2dsx, a
plasmid splicing reporter target containing a minigene of
two exons with a weak splice site from the Drosophila dsx
gene with or without an exonic splicing enhancer (ESE)
(Figure 5A, Supplementary Figure S4A). ESEs are re-
cognized by SR proteins, which interact with the splicing
machinery to stimulate the inclusion of weak exons (38).
Indeed, without a strong activator recruited to its 50 UASs
and CTD phosphorylation, G5HIV2dsx is transcribed
at low levels and its transcripts are processed inefﬁ-
ciently (29,39). However, because it has a very short coding
sequence (84 and 70 nucleotide exon fragments with a 114
nucleotide intron), we used the longer G5HIV2SVEDA
for our ChIPs. As presented in Supplementary Figure S2,
the WT GAL.AIRE fusion protein also activated
G5HIV2dsx. To visualize AIRE-induced effects on co-
transcriptional splicing of this minigene, we used a
primer pair that ampliﬁed spliced and unspliced tran-
scripts for RT-PCR. When the WT GAL.AIRE fusion
protein was co-expressed with G5HIV2dsx, we detected
more spliced (lower band) than unspliced transcripts
(upper band) compared to GAL (Figure 5B, compare
upper and lower bands in lanes 2 and 1). Interestingly, a
similar trend was observed when we co-expressed just the
AIRE TAD fused to GAL (GAL.AIRE488) (Figure 5B,
compare lanes 2 and 4). In contrast, the mutant
GAL.AIREfsx fusion protein did not have this effect
(Figure 5B, compare lanes 1–3). Using the plasmid
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Figure 4. AIRE increases S2P phosphorylation. (A) Schematic representation of the G5HIV2SVEDA minigene and ChIP amplicons is as in
Figure 3B. (B–D) ChIP of G5HIV2SVEDA. Transfected cells were analyzed with speciﬁc antibodies as in Figure 3B. (B) ChIP with anti-GAL
(aGAL) antibodies. (C) ChIP with anti-RNAPII (aRNAPII) antibodies. (D) ChIP with anti-S2P (aS2P) antibodies. (E) AIRE increases relative
levels of S2P. To evaluate relative levels, levels of S2P were normalized to those of RNAPII (S2P/RNAPII) for each amplicon. Error bars
represent SEM.
Nucleic Acids Research, 2011,Vol.39, No. 18 7913target lacking the ESE, we observed faint bands of spliced
transcripts when the WT GAL.AIRE or GAL.AIRE488
fusion proteins were co-expressed, but these levels were
much lower than those with the ESE-containing reporter
(Supplementary Figure S4B, lanes 1–4). All GAL fusion
proteins were expressed equivalently (Figure 5C and
Supplementary Figure S4C). We conclude that AIRE
increases the pre-mRNA splicing.
Prompted by these results and previous ﬁndings on
co-transcriptional accumulation of cellular splicing factors
(40), we examined if AIRE-induced increase of S2P
stimulated the recruitment of spliceosome component
U5 to our plasmid target. To this end, we examined the
abundance of spliceosome subunits with anti-U5-116 kD
antibodies by ChIP (Figure 5D, compare black and white
bars). U5–116 kD (U5) is a subunit of U5 snRNP, which
is a shared component of both the major U2 and minor
U12 spliceosomes (41). Indeed, we observed an enrich-
ment of U5 on the 30-end of the gene in cells expressing
the WT GAL.AIRE fusion protein. Thus, AIRE increases
the recruitment of co-transcriptional processing factors
to DNA that accumulate with RNAPII at the 30-end of
the gene.
Inhibition of CDK9 abrogates effect of AIRE on
pre-mRNA splicing
To examine if AIRE-induced increase of pre-mRNA
splicing and increased S2P levels were linked, we made
use of a pharmacological inhibitor of P-TEFb.
Flavopiridol (FP) binds tightly to the ATP pocket of
CDK9 and thereby inhibits its kinase activity (42). To
this end, we co-expressed the WT GAL.AIRE fusion
protein or GAL with G5HIV2dsx and compared splicing
patterns between FP-treated and untreated cells. The
reported half maximal inhibitory concentration of FP
for the kinase activity CDK9 is 22nM (43). Thus, we
used a low concentration to minimize effects of FP on
other CDKs. As presented in Figure 6A (compare lanes
2 and 1), when treating cells with FP at 25nM, we ob-
served a clear reduction in S2P levels in cells. We observed
no decrease in cell proliferation after 24h of treatment.
The expression of the WT GAL.AIRE fusion protein
or GAL in untreated as well as FP-treated cells was
conﬁrmed with speciﬁc antibodies by western blotting
(Figure 6B). From these cells, we isolated RNA and
used speciﬁc primers for spliced, unspliced and total dsx
RNA (Figure 6C, upper panel) and RT–qPCR to measure
activation of splicing by AIRE. Splicing efﬁciencies were
calculated as ratios of normalized levels of spliced versus
unspliced transcripts. In agreement with our earlier
results, when we compared splicing efﬁciency in untreated
cells, we detected a nearly 3.5-fold increased pre-mRNA
splicing with the WT GAL.AIRE fusion protein compared
to GAL (Figure 6C, compare black and white bars). By
contrast, in FP-treated cells, no such AIRE-induced
increase was observed (Figure 6C, compare black and
white bars). Thus, by inhibiting the kinase activity
of CDK9, AIRE-induced enhancement of pre-mRNA
splicing is blocked.
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Figure 5. AIRE increases pre-mRNA splicing. (A) Schematic representation of the G5HIV2dsx minigene with the RT–PCR primer pair. G5HIV2dsx
contains 5 GAL-binding sites (UAS) upstream of the Drosophila doublesex (dsx) exons 3 and 4 and the intervening sequence (intron) with an exonic
splicing enhancer (ESE) containing 6 GAA repeats and the SV40 poladenylation signal (pA). (B) AIRE affects splicing of dsx pre-mRNA. HeLa cells
co-expressed GAL or GAL fusion proteins and G5HIV2dsx. Total mRNA was isolated and splicing was assayed by RT–PCR with a primer
pair that ampliﬁed spliced (lower band) and unspliced (upper band) transcripts (RT–PCR). (C) Expression of fusion proteins was monitored
with anti-GAL antibodies by western blotting (WB). GAL and GAL.AIRE fusion proteins are identiﬁed by arrows. (D) U5 snRNP is enriched
on G5HIV2SVEDA in AIRE expressing cells. Sonicated lysates from HeLa cells co-expressing GAL or GAL.AIRE fusion protein and
G5HIV2SVEDA were immunoprecipitated with anti-U5 (aU5) antibodies for ChIP. Increased levels of speciﬁc amplicons are presented as fold
enrichment over the IgG control (U5/IgG). Black and white bars represent values for the GAL.AIRE chimeras and GAL, respectively, with
SEM depicted by error bars. G5HIV2SVEDA with amplicons is diagrammed above the bar graph (promoter, Pr; 50-end of gene, 50;3 0-end of
gene, 30; polyadenylation signal, pA). It contains ﬁve GAL binding sites (UAS) upstream of a-globin gene (agl) with inserted fragment of ﬁbronectin
1 gene (FN1).
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Since FP may inhibit other CDKs, to validate further the
role of CDK9 in AIRE-induced enhancement of splicing,
we also knocked-down CDK9 with siRNA and examined
AIRE-induced splicing. As presented in Figure 7A, CDK9
levels were decreased after 24h and were depleted at 48h.
The corresponding siRNA and G5HIV2dsx were co-
expressed with GAL or WT GAL.AIRE fusion proteins.
The expression of protein effectors and CDK9 knock-
downs were validated with speciﬁc antibodies by western
blotting (Figure 7B). From these cells, RNA was isolated
and levels of spliced and unspliced mRNAs were quanti-
ﬁed as in Figure 6C. When comparing splicing efﬁciencies
in cells transfected with control siRNA, we also ob-
served 4.5-fold increased pre-mRNA splicing by AIRE
(Figure 7C, compare black and white bars) which was
comparable to effects in untreated cells (Figure 6C).
Underlining the speciﬁc requirement for P-TEFb, AIRE
had no effect when expressed in cells depleted of CDK9
(Figure 7C, compare black and white bars). Thus, AIRE
requires P-TEFb to enhance pre-mRNA splicing.
By recruiting P-TEFb, AIRE induces splicing of an
endogenous TRA gene
To validate our model, we examined the endogenous
KRT14 gene, which is regulated by AIRE (18). Total
RNA was isolated from 293T cells expressing transiently
the empty plasmid vector, WT AIRE or mutant AIREfsx
proteins (Figure 8B). Spliced KRT14 and KRT14 intron
containing transcripts were ampliﬁed with speciﬁc primers
by RT–qPCR (Figure 8A) and quantiﬁed relative to those
from the endogenous GAPDH gene. As presented in
Supplementary Figure S5A, the expression of KRT14
was induced by the WT AIRE but not mutant AIREfsx
proteins. Splicing efﬁciencies were calculated as ratios of
normalized levels of spliced versus unspliced transcripts
and are presented as fold activation above the splicing
observed in the presence of only the empty plasmid
vector, which was set to 1. WT AIRE protein increased
the splicing efﬁciency 9-fold above the control (Figure 8C,
compare black to white bars). As expected, mutant
AIREfsx protein did not affect the splicing efﬁciency of
the KRT14 gene (Figure 8C, compare striped to white
bars). Similar results were obtained for the S100A8 gene,
which is also induced by AIRE (data not shown). We
conclude that the mutant AIREfsx protein affects
neither the transcription nor the splicing of endogenous
TRA genes, which is in agreement with our observations
with plasmid targets.
To examine further the role of P-TEFb in AIRE-
induced expression of TRA genes, we compared levels
of KRT14 mRNA from cells expressing the WT AIRE
protein which were treated or not with FP (Figure 8D).
Indeed, effects of AIRE were decreased by 85% in cells
treated with FP compared to untreated cells
(Supplementary Figure S5B, compare black bars). FP
also inhibited AIRE-induced splicing of KRT14
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Figure 7. AIRE requires CDK9 for its effects on pre-mRNA splicing.
(A) Time course of CDK9 siRNA knockdown. HeLa cells were trans-
fected with CDK9 or control siRNAs (cntrl). Subsequently, cells were
harvested at various time-points and protein levels were determined
with speciﬁc antibodies by western blotting. In the upper and lower
panels, levels of CDK9 and GAPDH are presented, respectively.
(B) Protein effectors are expressed in CDK9-knockdown cells. HeLa
cells were co-transfected with CDK9 or control siRNAs. GAL or the
WT GAL.AIRE chimera and G5HIV2dsx were co-expressed as
indicated. Protein levels of expressed proteins are presented in the
upper two panels with those of CDK9 and tubulin in the lowest
panels, respectively. (C) CDK9 siRNA knock-down inhibits effects of
AIRE on splicing. Upper panel contains a schematic representation of
the G5HIV2dsx minigene with amplicons used to amplify spliced,
unspliced or total dsx transcripts by RT–qPCR. Relative splicing efﬁ-
ciency was determined and is presented for the WT GAL.AIRE
chimera (black bars) as fold activation relative to GAL (white bars)
for cells transfected with CDK9 or control siRNAs. Error bars repre-
sent SEM.
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Figure 6. Flavopiridol inhibits effects of AIRE on splicing.
(A) Flavopiridol decreases total levels of S2P. Lysates from Hela
cells, which were treated with 25nM ﬂavopiridol (FP) or DMSO only
(C) for 24h, were analyzed with speciﬁc antibodies by western blotting
(WB). The upper panel presents levels of S2P. Lower panel presents
levels of GAPDH. (B) GAL fusion proteins and G5HIV2dsx are ex-
pressed in cells treated with FP. HeLa cells co-expressing G5HIV2dsx
and GAL or the WT GAL.AIRE chimera were treated with 25nM FP
or DMSO only for 24h as indicated. Expression of proteins was
determined with anti-GAL antibodies by western blotting (WB).
GAL and GAL.AIRE fusion proteins are indicated by arrows.
(C) FP blocks AIRE-induced enhancement of pre-mRNA splicing.
Upper panel presents schematic representation of G5HIV2dsx
minigene with probes used for RT–qPCR that speciﬁcally ampliﬁed
spliced, unspliced or total dsx transcripts. Relative splicing efﬁciency
was determined and is presented for the WT GAL.AIRE chimera
(black bars) as fold activation relative to GAL (white bars) for
treated and untreated cells (FP, DMSO). Error bars represent SEM.
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In these cells, AIRE was expressed at comparable levels
(Figure 8D). Thus, AIRE requires P-TEFb to induce tran-
scription and pre-mRNA splicing of endogenous TRA
genes.
These results and a previous report of the recruitment of
P-TEFb by AIRE to endogenous genes (10) led us to
examine if the mutant AIREfsx protein fails to do the
same. In 293T cells, we expressed transiently the empty
plasmid vector, WT AIRE or mutant AIREfsx proteins.
Subsequently, we performed ChIPs with anti-CDK9
antibodies and analyzed KRT14 DNA enrichment by
qPCR. qPCR amplicons are presented in the schematic
of the KRT14 gene above the bar graph (Figure 8F).
Indeed, we observed a signiﬁcant enrichment of CDK9
at the promoter (4.5-fold), in the coding region (26- and
14-fold) and at the polyadenylation site (6-fold) in WT
AIRE protein-expressing cells compared to control cells
(Figure 8F, compare black to white bars). Importantly, no
signiﬁcant enrichment was observed in mutant AIREfsx
protein-expressing cells (Figure 8F, striped bars). With
anti-S2P antibodies, we examined levels of S2P on the
KRT14 gene. They were also enriched between 2- and
4-fold in WT AIRE protein-expressing cells compared to
control and mutant AIREfsx protein-expressing cells
(Figure 8G, compare black to white and striped bars).
We conclude that by recruiting P-TEFb to endogenous
TRA genes, AIRE also increases their levels of S2P.
DISCUSSION
By characterizing the functional defect caused by an
APECED patient mutation, resulting in a frame-shift at
position 505 in AIRE (AIREfsx), we elucidated the mech-
anisms of AIRE-induced activation of otherwise tissue-
restricted genes. This mutation affects only the
C-terminus of AIRE, which is highly conserved between
mouse and human AIRE proteins. The mutant AIREfsx
protein could not activate exogenous plasmid targets or
representative endogenous TRA genes. This situation per-
sisted even when AIRE proteins were targeted artiﬁcially
to DNA via the GAL4 DNA-binding domain. This heter-
ologous tethering also allowed us to map the minimal
AIRE TAD, which was found to mediate interactions
with P-TEFb. Next, the mutant AIREfsx protein could
not recruit P-TEFb to plasmid DNA via heterologous
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Figure 8. By recruiting P-TEFb, AIRE induces splicing of an endogenous TRA gene. (A) Schematic representation of the KRT14 gene with primer
pairs used to amplify spliced and unspliced transcripts by RT–qPCR. (B) WT AIRE and mutant AIREfsx proteins are expressed in 293T cells.
Expression of proteins was determined with anti-AIRE and anti-a-tubulin antibodies by western blotting (WB). (C) Only the WT AIRE protein
induces splicing of the KRT14 pre-mRNA. Relative splicing efﬁciency was determined and is presented for WT AIRE (black bar) and mutant
AIREfsx (hashed bar) proteins as fold activation relative to the empty plasmid vector (C, white bar). Error bars represent SEM. (D) WT AIRE
protein is expressed in 293T cells treated with FP. Expression of proteins was determined with anti-AIRE and anti-a-tubulin antibodies by western
blotting (WB). (E) FP blocks AIRE-induced enhancement of KRT14 pre-mRNA splicing. Relative splicing efﬁciency was determined and is presented
for the WT AIRE protein (black bars) as fold activation relative to the empty plasmid vector (C, white bars) for treated and untreated cells (FP,
DMSO). Error bars represent SEM. (F) P-TEFb is enriched on the KRT14 gene in cells expressing the WT AIRE protein. ChIPs were performed
with anti-CDK9 (aCDK9) and control IgG antibodies with lysates from 293T cells expressing the empty plasmid vector (C), WT AIRE or mutant
AIREfsx proteins. Enrichment of speciﬁc KRT14 amplicons is presented as fold enrichment over IgG control (CDK9/IgG). White, black and striped
bars represent values for the empty plasmid vector (C), WT AIRE and mutant AIREfsx proteins, respectively, with SEM depicted by error bars. The
KRT14 gene and ChIP amplicons are depicted above the bar graph (promoter, Pr; 50 of coding region, 50;3 0 of coding region, 30; polyadenylation
signal, pA). (G) ChIP with anti-S2P (aS2P) antibodies. Expression levels for AIRE and a-tubulin proteins are presented below the bar graph (WB).
Lysates from transfected cells were analyzed with speciﬁc antibodies by western blotting.
7916 Nucleic Acids Research, 2011,Vol.39, No. 18DNA-tethering or to an endogenous TRA gene in chro-
matin when expressed transiently in cells. It also lost the
ability of its WT counterpart to increase levels of RNAPII
and CTD phosphorylation on the body and 30-end of
these target genes. These increased levels of S2P could
be correlated with those of speciﬁc transcripts and
improved co-transcriptional pre-mRNA processing of
minigene plasmid targets and an endogenous TRA gene
in chromatin. Of note, when the kinase activity of CDK9
was blocked by ﬂavopiridol or its levels diminished by
CDK9 siRNA, the WT AIRE protein also lost the
ability to increase the pre-mRNA splicing of its target
genes. In conclusion, we mapped the AIRE TAD,
deﬁned its interaction with P-TEFb, as well as
characterized functional consequences of this binding on
transcription of target genes and co-transcriptional pro-
cessing of their nascent transcripts.
This study conﬁrms and extends a previous observation
on interactions between AIRE and P-TEFb (10).
Importantly, we observed effects of increased levels of
S2P on co-transcriptional processing of nascent tran-
scripts. Moreover, enhanced splicing efﬁciencies and
increased levels of steady state mRNAs correlated
directly with CTD phosphorylation. Thus, our ﬁndings
complement nicely a previous report, which reported
that AIRE exerts most of its effects on gene expression
at the level of pre-mRNA splicing (18). In their proteomic
analysis, Abramson et al. identiﬁed 45 candidates that
interacted with AIRE and were involved in nuclear trans-
port, DNA-damage response, chromatin remodeling,
transcription and pre-mRNA processing. Knockdowns
of only 11 of these candidates impaired AIRE’s ability
to regulate the expression of target genes in chromatin
and on episomal plasmids. Of interest, except for the
Myb binding protein 1A (MYBBP1A), all of them were
found associated with P-TEFb and/or RNAPII in another
study (44). Since chromatin remodeling factors, splicing
and polyadenylation machineries bind to the elongating
transcription complex (26), associations between AIRE,
P-TEFb and RNAPII can better explain these proteomic
data than the ability of AIRE to bind all these proteins
directly. Thus, AIRE enters a long list of transcription
factors that recruit P-TEFb to target genes (22). Of
interest, mono-ubiquitylation increases the afﬁnity of
VP16 and other TADs for P-TEFb (37,45). Since AIRE
is ubiquitylated (15), this post-translational modiﬁcation
could also increase interactions between AIRE and
CDK9.
How AIRE is targeted precisely to TRA genes in
mTECs remains to be investigated. Since AIRE increases
the expression of so many genes, it is clear that this
binding has to be rather promiscuous. One aspect of this
recruitment is the binding between PHD1 and histone
H3K4me
0 (13,14,46). However, AIRE activated exogen-
ous plasmid targets in this and other studies, on which
chromatin does not assemble efﬁciently (47).
Furthermore, mutations outside the PHD1, e.g. in the
SAND domain, prevent the recruitment of AIRE to
target genes (35). Irrespective of this remaining conun-
drum, since P-TEFb does not initiate transcription,
genes that are activated by AIRE will contain RNAPII
already engaged on or near their promoters (48). The re-
cruitment of P-TEFb will then modify these transcription
complexes for elongation and co-transcriptional process-
ing of target genes. Different levels of engaged but stalled
transcription complexes on promoters could then explain
why clones of primary mTECs isolated from the mouse
thymus display different proﬁles of AIRE-induced TRAs
(49).
Our study also ﬁnds resonance with whole genome ana-
lyses of P-TEFb target genes, for example those regulated
by the proto-oncogene c-Myc (48). Similar to that situ-
ation, we ﬁnd that AIRE does not increase levels of
RNAPII at the promoter but rather in the body and es-
pecially at the 30-end of susceptible genes. This ﬁnding sug-
gests that P-TEFb phosphorylates preferentially subunits
of negative elongation factors at the 50-end of transcrip-
tion units, which must be modiﬁed to allow RNAPII to
elongate (22). Since P-TEFb remains associated with the
transcription complex in the body and 30-end of the gene,
S2P levels will increase throughout elongation. Our ChIPs
with anti-U5 antibodies revealed that spliceosome compo-
nents were enriched at the 30-end of the gene. This ﬁnding
suggests that RNAPII accumulates at these 30-ends to
permit optimal co-transcriptional processing, i.e. pre-
mRNA splicing and polyadenylation, which might not
go to completion during the actual transcription of these
sequences. In other words, transcription complexes might
move too quickly for this maturation of primary tran-
scripts to occur in situ (50). Consistent with this notion,
two recent studies reported that RNAPII pauses for
pre-mRNA splicing at the 30-end of the gene in
Saccharomyces cerevisiae (51,52). In summary, a single
nucleotide mutation from an APECED patient leading
to a mutant AIRE protein has allowed us to dissect these
steps more precisely and to deﬁne how genes can be regu-
lated in cells by a single protein, in this case for the speciﬁc
purpose of directing central tolerance and prevent deleteri-
ous immune responses against self, which can result in
autoimmunity.
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